Table 4.
Variables | Hazard ratio | 95% Confidence interval | P |
---|---|---|---|
Frailty category I | 1 (reference) | — | — |
Frailty category II | 1.51 | [0.84–2.72] | 0.169 |
Frailty category III | 2.37 | [1.32–4.23] | 0.004 |
Frailty category IV | 2.66 | [1.45–4.89] | 0.002 |
Age, per 1 SD | 1.04 | [0.83–1.31] | 0.730 |
Women | 0.84 | [0.61–1.14] | 0.266 |
Past HF hospitalization | 2.51 | [1.83–3.43] | <0.001 |
SBP at discharge, per 1 SD | 1.08 | [0.91–1.27] | 0.376 |
HR at discharge, per 1 SD | 1.08 | [0.94–1.25] | 0.282 |
Diabetes | 1.24 | [0.91–1.68] | 0.167 |
Past cardiac surgery | 0.97 | [0.66–1.43] | 0.896 |
Cancer | 1.21 | [0.76–1.91] | 0.419 |
COPD | 1.17 | [0.68–2.00] | 0.567 |
Orthopaedic disease | 0.84 | [0.45–1.57] | 0.585 |
Stroke | 0.44 | [0.13–1.42] | 0.171 |
High BNP level | 1.74 | [1.19–2.54] | 0.004 |
eGFR, per 1 SD | 0.80 | [0.67–0.95] | 0.013 |
Sodium, per 1 SD | 0.91 | [0.79–1.04] | 0.186 |
Anaemia | 1.19 | [0.84–1.68] | 0.334 |
Albumin, per 1 SD | 0.89 | [0.77–1.04] | 0.140 |
LVEF < 40% | 1.05 | [0.75–1.48] | 0.775 |
Beta blocker | 0.98 | [0.70–1.37] | 0.907 |
ACEi/ARB | 0.82 | [0.60–1.10] | 0.181 |
MRA | 1.15 | [0.85–1.57] | 0.367 |
Diuretic | 1.42 | [0.89–2.26] | 0.138 |
Oral inotropic agent | 1.50 | [1.03–2.19] | 0.036 |
MMSE, per 1 SD | 0.91 | [0.84–0.99] | 0.049 |
Depression | 1.30 | [0.97–1.76] | 0.081 |
BMI, per 1 SD | 0.85 | [0.70–1.13] | 0.096 |
ACEi, angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, brain natriuretic peptide; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; HF, heart failure; HR, heart rate; LVEF, left ventricular ejection fraction; MMSE, Mini‐Mental State Examination; MRA, mineral corticoid antagonist; SBP, systolic blood pressure.
Anaemia is defined as haemoglobin < 13 g/dL for men and <12 g/dL for women. High BNP level was defined as BNP ≥ 200 pg/mL or N‐terminal pro BNP ≥ 900 pg/mL. Depression is defined as 5‐item Geriatric Depression Scale ≥ 2 points.